Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. News
  7. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 01/20 02:25:15 pm
406 EUR   +4.91%
01/04SARTORIUS VORZUEGE : Gets a Buy rating from JP Morgan
MD
2021SARTORIUS VORZUEGE : NorldLB gives a Neutral rating
MD
2021Sartorius Acquires Majority Stake in ALS Automated Lab Solutions
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sartorius to Invest Around EUR270 Million in South Korea Expansion

11/25/2021 | 06:35am EST

By Cecilia Butini

Sartorius AG said Thursday that it is investing around 270 million euros ($302.4 million) through the end of 2024 in an expansion of its business in South Korea.

The German biopharmaceutical company said it plans to launch cell-culture media production and assemble sterile systems for biopharmaceutical manufacturing in the Songdo biopharma hub.

About 750 new jobs will be created at the site in Incheon, South Korea, and construction is planned to begin in the coming year, Sartorius said. Production is set to start by the end of 2024, the company said.

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

11-25-21 0635ET

All news about SARTORIUS AG
01/04SARTORIUS VORZUEGE : Gets a Buy rating from JP Morgan
MD
2021SARTORIUS VORZUEGE : NorldLB gives a Neutral rating
MD
2021Sartorius Acquires Majority Stake in ALS Automated Lab Solutions
DJ
2021Sartorius To Buy 63% Interest In Germany's ALS Automated Lab Solutions
MT
2021Sartorius Aktiengesellschaft entered into an agreement to acquire a 62.5% stake in ALS ..
CI
2021SARTORIUS : and HOF Sonderanlagenbau Partnership Creates...
PU
2021Sartorius to Pay $11.3 Million COVID-19 Bonus to Employees
MT
2021SARTORIUS : employees to receive a bonus for their commitment and...
PU
2021Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs
DJ
2021Sartorius to Invest Around EUR270 Million in South Korea Expansion
DJ
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Financials
Sales 2021 3 397 M 3 844 M 3 844 M
Net income 2021 418 M 473 M 473 M
Net Debt 2021 1 885 M 2 134 M 2 134 M
P/E ratio 2021 65,0x
Yield 2021 0,34%
Capitalization 30 331 M 34 393 M 34 326 M
EV / Sales 2021 9,48x
EV / Sales 2022 8,27x
Nbr of Employees 12 952
Free-Float 33,3%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | SRT | DE0007165607 | MarketScreener
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 387,00 €
Average target price 488,55 €
Spread / Average Target 26,2%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG-22.44%32 723
REVENIO GROUP OYJ-11.32%1 485
BIOTAGE AB (PUBL)-29.43%1 341
VAREX IMAGING CORPORATION-12.08%1 098
CELLAVISION AB (PUBL)-2.03%835
RENALYTIX PLC-12.58%534